Aveanna Healthcare (AVAH) Registration Filing summary
Event summary combining transcript, slides, and related documents.
Registration Filing summary
16 Dec, 2025Management team and governance
President and CEO is Jeff Shaner, who also serves as a director.
Matthew Buckhalter is the Chief Financial Officer.
Deborah Stewart is Senior Vice President and Chief Accounting Officer.
Board includes Rodney D. Windley (Chairman), Victor F. Ganzi, Christopher R. Gordon, Devin O'Reilly, Sheldon M. Retchin, Steven E. Rodgers, Erica Schwartz, and Robert M. Williams, Jr.
Directors and officers are indemnified to the fullest extent permitted by Delaware law, with additional indemnification agreements and D&O insurance in place.
Offering details and pricing
Registration statement filed on Form S-3 for a shelf offering, allowing securities to be sold from time to time as determined by market conditions.
$101,942 listed as the SEC registration fee; other offering expenses to be provided by amendment.
Includes forms for various securities: senior and subordinated notes, warrants, subscription rights, and units.
Underwriters and syndicate
Form of Underwriting Agreement included as an exhibit; specific underwriters not named in the filing.
Latest events from Aveanna Healthcare
- Accelerated growth and margin expansion driven by acquisitions, payer strategy, and financial discipline.AVAH
46th Annual William Blair Growth Stock Conference2 Jun 2026 - Q1 2026 revenue rose 15.9% and adjusted EBITDA 25.2%, driven by value-based homecare growth.AVAH
Investor presentation15 May 2026 - Q1 revenue and earnings surged, with raised guidance and a major pediatric care acquisition pending.AVAH
Q1 202614 May 2026 - Director elections, auditor ratification, and say-on-pay vote headline the annual meeting agenda.AVAH
Proxy filing17 Apr 2026 - Strong financial results, board elections, auditor ratification, and executive pay up for vote.AVAH
Proxy filing17 Apr 2026 - Strong revenue growth and value-based care drive expansion in a $119bn homecare market.AVAH
Investor presentation20 Mar 2026 - Double-digit revenue and profit growth in 2025, robust 2026 outlook, major acquisition announced.AVAH
Q4 202519 Mar 2026 - Q2 revenue up 7% to $505M, adjusted EBITDA up 27%, guidance raised despite lower net income.AVAH
Q2 20242 Feb 2026 - Strategic transformation and rate wins drive growth, staffing, and margin expansion in 2024.AVAH
Healthcare Services Conference1 Feb 2026 - Accelerating growth via preferred payer strategy, targeting $200M EBITDA by 2026.AVAH
Jefferies Global Healthcare Conference1 Feb 2026